Literature DB >> 9353062

Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection.

C M Theodos1, K L Sullivan, J K Griffiths, S Tzipori.   

Abstract

This study describes healing and nonhealing models of Cryptosporidium parvum infection with adult mice that have functional T and B lymphocytes. In our nonhealing model, mice on a C57BL/6 background which have a targeted disruption in the gamma interferon (IFN-gamma) gene (GKO mice) are utilized. C. parvum-infected GKO mice shed extremely high levels of oocysts and displayed overwhelming infection of the entire small intestine. The majority of these mice succumbed within 2 to 3 weeks due to severe acute infection and profound mucosal destruction. In our healing murine model, C57BL/6J mice treated with a single injection of the neutralizing anti-IFN-gamma monoclonal antibody XMG 1.2 prior to infection were used. These mice developed two peaks of oocyst shedding but were ultimately free of parasites on day 30 of infection. Again, the small intestine was the primary site of infection. Mesenteric lymph node (MLN) cells isolated from C. parvum-infected nonhealing GKO mice proliferated and secreted interleukin 2 (IL-2) but not IFN-gamma or IL-4 in response to ex vivo restimulation with intact C. parvum sporozoites or a C. parvum sporozoite antigen preparation. In contrast, parasite-specific MLN cells isolated from healing C57BL/6J mice secreted IL-2 and IFN-gamma but not IL-4. These results suggest that IFN-gamma, either directly or indirectly, is important for resistance to and resolution of cryptosporidiosis. Moreover, these models now allow the analysis of parasite-specific cell-mediated and humoral mucosal immune responses to determine what constitutes protective immunity to C. parvum.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353062      PMCID: PMC175683          DOI: 10.1128/iai.65.11.4761-4769.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

1.  Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum.

Authors:  J M Bjorneby; B D Hunsaker; M W Riggs; L E Perryman
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

2.  New mouse models for chronic Cryptosporidium infection in immunodeficient hosts.

Authors:  B L Ungar; J A Burris; C A Quinn; F D Finkelman
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum.

Authors:  S Tzipori; D Roberton; D A Cooper; L White
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

4.  Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients.

Authors:  J Nord; P Ma; D DiJohn; S Tzipori; C O Tacket
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

5.  The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice.

Authors:  R Taghi-Kilani; L Sekla; K T Hayglass
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

6.  In vitro murine lymphocyte blastogenic responses to Cryptosporidium parvum.

Authors:  W M Whitmire; J A Harp
Journal:  J Parasitol       Date:  1990-06       Impact factor: 1.276

7.  Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum.

Authors:  B L Ungar; D J Ward; R Fayer; C A Quinn
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

8.  Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus).

Authors:  J A Ernest; B L Blagburn; D S Lindsay; W L Current
Journal:  J Parasitol       Date:  1986-10       Impact factor: 1.276

9.  Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans.

Authors:  J R Mead; M J Arrowood; C R Sterling
Journal:  J Parasitol       Date:  1988-02       Impact factor: 1.276

10.  Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice.

Authors:  M J Arrowood; J R Mead; J L Mahrt; C R Sterling
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

View more
  40 in total

1.  Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets.

Authors:  H Uronen; R E Callard
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 3.  Intestinal immune response to human Cryptosporidium sp. infection.

Authors:  Birte Pantenburg; Sara M Dann; Heuy-Ching Wang; Prema Robinson; Alejandro Castellanos-Gonzalez; Dorothy E Lewis; A Clinton White
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

4.  MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice.

Authors:  K A Rogers; A B Rogers; B A Leav; A Sanchez; E Vannier; S Uematsu; S Akira; D Golenbock; H D Ward
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells.

Authors:  Birte Pantenburg; Alejandro Castellanos-Gonzalez; Sara M Dann; Rhykka L Connelly; Dorothy E Lewis; Honorine D Ward; A Clinton White
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

6.  Intranasal vaccination in mice with an attenuated Salmonella enterica Serovar 908htr A expressing Cp15 of Cryptosporidium: impact of malnutrition with preservation of cytokine secretion.

Authors:  James K Roche; Ana Lara Rojo; Lourrany B Costa; Ronald Smeltz; Patricio Manque; Ute Woehlbier; Luther Bartelt; James Galen; Gregory Buck; Richard L Guerrant
Journal:  Vaccine       Date:  2012-12-16       Impact factor: 3.641

7.  Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species.

Authors:  D E Akiyoshi; X Feng; M A Buckholt; G Widmer; S Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum.

Authors:  J K Griffiths; C Theodos; M Paris; S Tzipori
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Inactivation of Cryptosporidium parvum oocysts in fresh apple cider by UV irradiation.

Authors:  D E Hanes; R W Worobo; P A Orlandi; D H Burr; M D Miliotis; M G Robl; J W Bier; M J Arrowood; J J Churey; G J Jackson
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

10.  Induced susceptibility of host is associated with an impaired antioxidant system following infection with Cryptosporidium parvum in Se-deficient mice.

Authors:  Chengmin Wang; Yanyun Wu; Jianhua Qin; Haoxue Sun; Hongxuan He
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.